Moderna Announces Phase 1 Clinical Trials for Heart Failure mRNA Therapy

“We’re very happy to announce this morning a very exciting program in cardiology for chronic heart failure. As you know it’s a massive medical problem around the world,” stated Stéphane Bancel, CEO of Moderna.